PMID- 31908405 OWN - NLM STAT- MEDLINE DCOM- 20200619 LR - 20200619 IS - 1090-0535 (Electronic) IS - 1090-0535 (Linking) VI - 25 DP - 2019 TI - Sector retinitis pigmentosa: Report of ten cases and a review of the literature. PG - 869-889 AB - PURPOSE: To describe the genotypes and phenotypes of ten patients with sector retinitis pigmentosa (RP). We also review previously reported mutations associated with sector RP and provide a discussion of possible underlying pathophysiological mechanisms. METHODS: Patients underwent detailed ophthalmologic examinations, fundus photography, fundus autofluorescence (FAF) imaging, spectral-domain optical coherence tomography (SD-OCT), as well as visual field and electroretinographic testing. All patients underwent genetic testing to identify the molecular etiology of their disease. RESULTS: A total of ten patients were studied. Among these patients, nine had mutations in RHO (c.677T>C; p.Leu226Pro (novel), c.68C>A; p.Pro23His, c.808A>C; p.Ser270Arg, c.44A>G; p.Asn15Ser, and c.325G>A; p.Gly109Arg), and one patient had a mutation in RPGR (c.3092_3093delAG; p.Glu1031Glyfs*47). All patients with missense mutations in RHO had visual acuities (VAs) better than 20/30 and showed a retained foveal ellipsoid zone and overlying retinal structures. The patient with the c.3092_3093delAG deletion in RPGR had VA of 20/60 oculus dexter (OD) and 20/400 oculus sinister (OS), as well as significant foveal thinning and contour atrophy. All patients showed pigmentary changes, or marked atrophy along the inferior arcades, or both. This pattern of degeneration corresponded to hypo- and hyperFAF and superior visual defects. CONCLUSIONS: Sector RP is an uncommon form of RP in which only one or two retinal quadrants display clinical pathological signs. The great majority of cases result from mutations in RHO. The present data confirmed previously reported phenotypic manifestations of sector RP. Inferior retinal quadrants are possibly more severely affected due to greater light exposure. CI - Copyright (c) 2019 Molecular Vision. FAU - Coussa, Razek Georges AU - Coussa RG AD - Center for Genetic Eye Diseases, Cole Eye Institute, Cleveland Clinic, Cleveland, OH. FAU - Basali, Diana AU - Basali D AD - Center for Genetic Eye Diseases, Cole Eye Institute, Cleveland Clinic, Cleveland, OH. FAU - Maeda, Akiko AU - Maeda A AD - Department of Ophthalmology & Visual Sciences, Case Western Reserve University School of Medicine, Cleveland, OH. FAU - DeBenedictis, Meghan AU - DeBenedictis M AD - Center for Genetic Eye Diseases, Cole Eye Institute, Cleveland Clinic, Cleveland, OH. FAU - Traboulsi, Elias I AU - Traboulsi EI AD - Center for Genetic Eye Diseases, Cole Eye Institute, Cleveland Clinic, Cleveland, OH. LA - eng PT - Case Reports PT - Journal Article PT - Review DEP - 20191230 PL - United States TA - Mol Vis JT - Molecular vision JID - 9605351 RN - 9009-81-8 (Rhodopsin) SB - IM MH - Amino Acid Sequence MH - Animals MH - Humans MH - Mutation/genetics MH - Phenotype MH - Retinitis Pigmentosa/diagnosis/diagnostic imaging/*genetics/physiopathology MH - Rhodopsin/chemistry/genetics MH - Visual Fields PMC - PMC6937219 EDAT- 2020/01/08 06:00 MHDA- 2020/06/20 06:00 PMCR- 2019/01/01 CRDT- 2020/01/08 06:00 PHST- 2019/04/06 00:00 [received] PHST- 2019/12/28 00:00 [accepted] PHST- 2020/01/08 06:00 [entrez] PHST- 2020/01/08 06:00 [pubmed] PHST- 2020/06/20 06:00 [medline] PHST- 2019/01/01 00:00 [pmc-release] AID - 80 [pii] PST - epublish SO - Mol Vis. 2019 Dec 30;25:869-889. eCollection 2019.